Rollins: Third Earnings Miss in Four Quarters Triggers Cut
Rollins reported Q3 adjusted EPS of $0.34, down 2.9% year over year despite 6.2% revenue growth, marking the third earnings miss in four quarters. Goldman Sachs cut its price target to $42 from $49, a
Goldman Cuts Rollins Target to $42 After Q3 EPS Miss
NEW YORK, October 22 —
Three misses in four quarters haven't yet cracked the premium at Rollins, Inc. (ROL). Goldman Sachs cut its target to $42 from $49 after Q3 adjusted EPS of $0.34 missed consensus by 2.9% and declined year over year, even as revenues grew 6.2%. At 27.7x forward earnings, the stock is priced for profit momentum the company has stopped generating.
- Q3 adjusted EPS $0.34, down 2.9% YoY; third miss in four quarters
- Q3 revenues $1.09 billion, up 6.2%; commercial up 7.7%, outpacing residential
- Goldman Sachs target cut to $42 from $49; consensus Hold, mean target $39.44
Cost Structure Is Absorbing the Revenue Gains
Rollins provides pest, termite, and wildlife control to residential and commercial customers across the United States and internationally, employing roughly 22,000 people. Q3 organic growth of 4.4% came from commercial and termite operations, which include healthcare, food service, and logistics clients that generate more predictable volume than consumer-direct channels. Revenue gains are being consumed by higher costs before reaching earnings, a recurring pattern, not a one-time event. With $502 million in trailing free cash flow against $1.12 billion in debt, the balance sheet isn't stressed, but the P&L is failing to deliver what the multiple demands.
Residential Is a Marketing Problem, Not Seasonal Softness
Management's candor about the residential segment offers little comfort. Consumer-initiated demand was weak across all major acquisition channels: traditional search, digital media, and inbound. The company acknowledged the need to reassess its marketing approach and improve customer acquisition spending effectiveness. Residential revenues grew 4.9% year over year to $499.7 million on a reported basis, but organic residential growth was only 2.3%, implying the rest arrived through acquisitions or pricing. A business reassessing its customer acquisition model while commercial carries the load has a strategy problem, not a seasonal one.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| ROL | $17.0B | 27.9x | -41.1% |
| IEX | $16.7B | 23.5x | +39.8% |
| JKHY | $11.3B | 20.5x | -1.5% |
| MTD | $33.8B | 32.5x | +16.7% |
| VRSK | $26.6B | 23.4x | -18.1% |
| ALLE | $15.0B | 18.0x | -7.1% |
The Multiple Must Justify Itself Next Quarter
Goldman Sachs' target cut matters less for its magnitude than its timing. A premium pest-control franchise commands a premium multiple only if earnings growth accompanies revenue growth, and the assumptions behind 27.7x are worth testing with a DCF model. The consensus Hold at a mean target of $39.44 implies further downside from $35.28. The number that changes the thesis is Q4 EPS: year-over-year earnings growth alongside residential recovery makes the multiple defensible; without it, further compression is the more likely path. Run the free Rollins, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What was Rollins Q3 earnings?
Rollins reported Q3 adjusted EPS of $0.34, down 2.9% year over year. This marks the third earnings miss in four quarters, despite revenue growth of 6.2% to $1.09 billion.
Why did Goldman Sachs cut its Rollins price target?
Goldman Sachs cut its target to $42 from $49 because revenue gains are being absorbed by higher costs before reaching earnings. At 27.7x forward earnings, the stock is priced for profit momentum the company is not delivering.
What's wrong with Rollins' residential segment?
The residential segment shows weak consumer-initiated demand across all acquisition channels. Residential organic growth was only 2.3%, far below the 4.4% company-wide organic growth rate, suggesting a strategy problem rather than seasonal weakness.
Does Rollins' balance sheet pose a risk?
No. Rollins has $502 million in trailing free cash flow against $1.12 billion in debt, so the balance sheet is not stressed. The problem is the P&L failing to convert revenue growth into earnings growth.
What would make the valuation defensible?
Goldman argues the multiple becomes defensible only if Q4 delivers year-over-year earnings growth alongside residential recovery. Without both, further stock price compression is more likely.
Goldman Sachs cut its Rollins price target from $49 to $42 after Q3 adjusted EPS of $0.34 missed consensus by 2.9% and declined year over year—the third miss in four quarters. Revenue is growing, but earnings are moving in the opposite direction at a company trading at 27.7x forward earnings.